Mechanisms of dendritic cell-based vaccination against infection

International Journal of Medical Microbiology

Volumn 298, Issue 1-2, 2008, Pages 11-20

  Fajardo Moser, Marcela ^a   Berzel, Simon ^a   Moll, Heidrun ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dendritic cells; Immune regulation; Infection; Vaccination

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 LIGAND; DENDRITIC CELL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL MATURATION; CELL SUBPOPULATION; DENDRITIC CELL; DRUG MECHANISM; EX VIVO STUDY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOREGULATION; IN VIVO STUDY; INFECTION; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; VACCINATION;

EID: 36749045921     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.07.003     Document Type: Short Survey

References (96)

1. Adams S., O'Neill D.W., and Bhardwaj N. Recent advances in dendritic cell biology. J. Clin. Immunol. 25 (2005) 87-98
2. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., and Pulendran B. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171 (2003) 4984-4989
3. Ahuja S.S., Reddick R.L., Sato N., Montalbo E., Kostecki V., Zhao W., Dolan M.J., Melby P.C., and Ahuja S.K. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 163 (1999) 3890-3897
4. Akiba H., Miyahira Y., Atsuta M., Takeda K., Nohara C., Futagawa T., Matsuda H., Aoki T., Yagita H., and Okumura K. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J. Exp. Med. 191 (2000) 375-380
5. Akira S. TLR signalling. Curr. Top. Microbiol. Immunol. 311 (2006) 1-16
6. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
7. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413 (2001) 732-738
8. Andersen-Nissen E., Smith K.D., Bonneau R., Strong R.K., and Aderem A. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J. Exp. Med. 204 (2007) 393-403
9. Balic A., Harcus Y., Holland M.J., and Maizels R.M. Selective maturation of dendritic cells by Nippostrongylus brasiliensis-secreted proteins drives Th2 immune responses. Eur. J. Immunol. 34 (2004) 3047-3059
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
11. Berberich C., Ramírez-Pineda J.R., Hambrecht C., Alber G., Skeiky Y.A.W., and Moll H. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J. Immunol. 170 (2003) 3171-3179
12. Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y.J., and O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197 (2003) 101-109
13. Boonstra A., Trinchieri G., and O'Garra A. The plasticity of DC populations in promoting Th cell responses. In: Lutz M.B., Romani N., and Steinkasserer A. (Eds). Handbook of Dendritic Cells. Biology, Diseases and Therapies (2006), Wiley-VCH Verlag GmbH & Co., Weinheim 385-404
14. Bourguin I., Moser M., Buzoni-Gatel D., Tielemans F., Bout D., Urbain J., and Leo O. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66 (1998) 4867-4874
15. Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., di Francesco P., and Romani L. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 168 (2002) 1362-1371
16. Briken V., Porcelli S.A., Besra G.S., and Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53 (2004) 391-403
17. Buchsel P.C., and DeMeyer E.S. Dendritic cells: emerging roles in tumor immunotherapy. Clin. J. Oncol. Nurs. 10 (2006) 629-640
18. Bullens D.M., Kasran A., Thielemans K., Bakkus M., and Ceuppens J.L. CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand. J. Immunol. 53 (2001) 455-463
19. Caux C., Ait-Yahia S., Chemin K., de Bouteiller O., Dieu-Nosjean M.C., Homey B., Massacrier C., Vanbervliet B., Zlotnik A., and Vicari A. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22 (2000) 345-369
20. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
21. Celluzzi C.M., and Falo Jr. L.D. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160 (1998) 3081-3085
22. Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., and Falo Jr. L.D. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183 (1996) 283-287
23. Chan C.W., Crafton E., Fan H.N., Flook J., Yoshimura K., Skarica M., Brockstedt D., Dubensky T.W., Stins M.F., Lanier L.L., Pardoll D.M., and Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12 (2006) 207-213
24. Cheng P., Nefedova Y., Miele L., Osborne B.A., and Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood 102 (2003) 3980-3988
25. Clemons K.V., Calich V.L., Burger E., Filler S.G., Grazziutti M., Murphy J., Roilides E., Campa A., Dias M.R., Edwards Jr. J.E., Fu Y., Fernandes-Bordignon G., Ibrahim A., Katsifa H., Lamaignere C.G., Meloni-Bruneri L.H., Rex J., Savary C.A., and Xidieh C. Pathogenesis I: interactions of host cells and fungi. Med. Mycol. 38 Suppl. 1 (2000) 99-111
26. Dakic A., and Wu L. Hemopoietic precursors and development of dendritic cell populations. Leuk. Lymphoma 44 (2003) 1469-1475
27. de Jong E.C., Vieira P.L., Kalinski P., Schuitemaker J.H., Tanaka Y., Wierenga E.A., Yazdanbakhsh M., and Kapsenberg M.L. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168 (2002) 1704-1709
28. de Jong E.C., Smits H.H., and Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26 (2005) 289-307
29. Demangel C., Bean A.G., Martin E., Feng C.G., Kamath A.T., and Britton W.J. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells. Eur. J. Immunol. 29 (1999) 1972-1979
30. d'Ostiani C.F., Del Sero G., Bacci A., Montagnoli C., Spreca A., Mencacci A., Ricciardi-Castagnoli P., and Romani L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191 (2000) 1661-1674
31. Doxsee C.L., Riter T.R., Reiter M.J., Gibson S.J., Vasilakos J.P., and Kedl R.M. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-α production in CD11c+CD11b+CD8- dendritic cells. J. Immunol. 171 (2003) 1156-1163
32. Eggert A.A.O., van der Voort R., Torensma R., Moulin V., Boerman O.C., Oyen W.J.G., Punt C.J.A., Diepstra H., de Boer A.J., Figdor C.G., and Adema G.J. Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol. Lett. 89 (2003) 17-24
33. Enk A.H. Dendritic cells in tolerance induction. Immunol. Lett. 99 (2005) 8-11
34. Figdor C.G., de Vries I.J., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10 (2004) 475-480
35. Flohé S.B., Bauer C., Flohé S., and Moll H. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol. 28 (1998) 3800-3811
36. Gorak P.M.A., Engwerda C.R., and Kaye P.M. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28 (1998) 687-695
37. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 111 (2002) 927-930
38. Grohmann U., Belladonna M.L., Bianchi R., Orabona C., Ayroldi E., Fioretti M.C., and Puccett P. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity 9 (1998) 315-323
39. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
40. Harrington L.E., Mangan P.R., and Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. 18 (2006) 349-356
41. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
42. Hemmi H., Kaisho T., Takeda K., and Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170 (2003) 3059-3064
43. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., and Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192 (2000) 823-833
44. Inaba K., Metlay J.P., Crowley M.T., and Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172 (1990) 631-640
45. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., Ozaki Y., Tomizawa H., Akira S., and Fukuhara S. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195 (2002) 1507-1512
46. Jacobson N.G., Szabo S.J., Guler M.L., Gorham J.D., and Murphy K.M. Regulation of interleukin-12 signal transduction during T helper phenotype development. Res. Immunol. 146 (1995) 446-456
47. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
48. Kaisho T., and Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117 (2006) 979-987
49. Knight S.C., Burke F., and Bedford P.A. Dendritic cells, antigen distribution and the initiation of primary immune responses to self and non-self antigens. Semin. Cancer Biol. 12 (2002) 301-308
50. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., and Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001) 2154-2163
51. Larmonier N., Merino D., Nicolas A., Cathelin D., Besson A., Bateman A., Solary E., Martin F., Katsanis E., and Bonnotte B. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis 11 (2006) 1513-1524
52. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23 (2005) 275-306
53. Lopez C.B., Fernandez-Sesma A., Czelusniak S.M., Schulman J.L., and Moran T.M. A mouse model for immunization with ex vivo virus-infected dendritic cells. Cell. Immunol. 206 (2000) 107-115
54. Lu H., and Zhong G. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect. Immun. 67 (1999) 1763-1769
55. Ludewig B., Ehl S., Karrer U., Odermatt B., Hengartner H., and Zinkernagel R.M. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72 (1998) 3812-3818
56. MacDonald A.S., Straw A.D., Bauman B., and Pearce E.J. CD8 dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167 (2001) 1982-1988
57. Mahnke K., and Enk A.H. Dendritic cells: key cells for the induction of regulatory T cells?. Curr. Top. Microbiol. Immunol. 293 (2005) 133-150
58. Maldonado-Lopez R., De Smedt T., Michel P., Godfroid J., Pajak B., Heirman C., Thielemans K., Leo O., Urbain J., and Moser M. CD8α+ and CD8α- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189 (1999) 587-592
59. Matzinger P. An innate sense of danger. Ann. NY Acad. Sci. 961 (2002) 341-342
60. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Garcia-Prats M.D., DeLeo A.B., and Lotze M.T. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1 (1995) 1297-1302
61. Mbow M.L., Zeidner N., Panella N., Titus R.G., and Piesman J. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect. Immun. 65 (1997) 3386-3390
62. McGreal E.P., Miller J.L., and Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr. Opin. Immunol. 17 (2005) 18-24
63. McKenna K., Beignon A.S., and Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79 (2005) 17-27
64. Micallef M.J., Takashi O., Keizo K., Fujimi T., Shimpei U., Motoshi N., Tadao T., Kakuji T., Mitsukiyo F., Masao I., Shigeharu F., and Masashi K. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26 (1996) 1647-1651
65. Moll H. Dendritic cells as a tool to combat infectious diseases. Immunol. Lett. 85 (2003) 153-157
66. Moll H. Antigen delivery by dendritic cells. Int. J. Med. Microbiol. 294 (2004) 337-344
67. Moser M., and Murphy K.M. Dendritic cell regulation of TH1TH2 development. Nat. Immunol. 1 (2000) 199-205
68. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2 (2002) 933-944
69. Netea M.G., Van der Meer J.W., Sutmuller R.P., Adema G.J., and Kullberg B.J. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49 (2005) 3991-3996
70. O'Shea J.J., and Paul W.E. Regulation of Th 1 differentiation: controlling the controllers. Nat. Immunol. 3 (2002) 506-508
71. Park A.Y., Hondowicz B.D., and Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165 (2000) 896-902
72. Pulendran B. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol. Res. 29 (2004) 187-196
73. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., and Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 1036-1041
74. Ramírez-Pineda J.R., Fröhlich A., Berberich C., and Moll H. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. J. Immunol. 172 (2004) 6281-6289
75. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 14 (2001) 495-498
76. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16 (2004) 27-34
77. Remer, K., Apetrei, C., Linden, C., Moll, H., 2007. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice. Eur. J. Immunol., in press.
78. Sabatte J., Maggini J., Nahmod K., Amaral M.M., Martinez D., Salamone G., Ceballos A., Giordano M., Vermeulen M., and Geffner J. Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function. Cytokine Growth Factor Rev. 18 (2007) 5-17
79. Schon E., Harandi A.M., Nordstrom I., Holmgren J., and Eriksson K. Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection. J. Reprod. Immunol. 50 (2001) 87-104
80. Schott M. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers. Endocr. Relat. Cancer 13 (2006) 779-795
81. Sher A., Hieny S., Charest H., Scharton-Kersten T., Collazo C., Germain R.N., and Reis e Sousa C. The role of dendritic cells in the initiation of host resistance to Toxoplasma gondii. Adv. Exp. Med. Biol. 452 (1998) 103-110
82. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
83. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7 (2007) 19-30
84. Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol. Med. 12 (2006) 167-176
85. Soruri A., and Zwirner J. Dendritic cells: limited potential in immunotherapy. Int. J. Biochem. Cell Biol. 37 (2005) 241-245
86. Steinman R.M., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137 (1973) 1142-1162
87. Steinman R.M., and Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311 (2006) 17-58
88. Steinman R.M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., Iyoda T., Ravetch J., Dhodapkar M., Inaba K., and Nussenzweig M. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci. 987 (2003) 15-25
89. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
90. Taieb J., Chaput N., Menard C., Apetoh L., Ullrich E., Bonmort M., Pequignot M., Casares N., Terme M., Flament C., Opolon P., Lecluse Y., Metivier D., Tomasello E., Vivier E., Ghiringhelli F., Martin F., Klatzmann D., Poynard T., Tursz T., Raposo G., Yagita H., Ryffel B., Kroemer G., and Zitvogel L. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12 (2006) 214-219
91. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
92. Takeda K., Takeuchi O., and Akira S. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 8 (2002) 459-463
93. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
94. von Stebut E., Belkaid Y., Jakob T., Sacks D.L., and Udey M.C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188 (1998) 1547-1552
95. Watford W.T., Moriguchi M., Morinobu A., and O'Shea J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14 (2003) 361-368
96. Zitvogel L., Angevin E., and Tursz T. Dendritic cell-based immunotherapy of cancer. Ann. Oncol. Suppl. 3 (2000) 199-205